What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
His primary scientific interests are in Immunology, Primary biliary cirrhosis, Genetics, Internal medicine and Autoimmunity.
His research on Immunology frequently connects to adjacent areas such as Comorbidity.
His work deals with themes such as Odds ratio, Disease, Pathology and Autoantibody, Antibody, which intersect with Primary biliary cirrhosis.
His Genetics research includes themes of Population genetics and Cohort.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Endocrinology.
The various areas that he examines in his Autoimmunity study include Anti-nuclear antibody, Adaptive response, Epigenetics and Antigen presentation.
His most cited work include:
- Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview‐based study of 1032 patients (445 citations)
- Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview‐based study of 1032 patients (445 citations)
- Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment ☆ (363 citations)
What are the main themes of his work throughout his whole career to date?
Carlo Selmi mostly deals with Immunology, Primary biliary cirrhosis, Internal medicine, Autoimmunity and Autoantibody.
Many of his studies involve connections with topics such as Disease and Immunology.
His Primary biliary cirrhosis study incorporates themes from Molecular mimicry, Antigen, Cirrhosis, Intrahepatic bile ducts and Etiology.
The various areas that Carlo Selmi examines in his Internal medicine study include Gastroenterology and Endocrinology.
His Autoimmunity course of study focuses on Genetic predisposition and Concordance.
His Autoimmune disease research is under the purview of Genetics.
He most often published in these fields:
- Immunology (72.57%)
- Primary biliary cirrhosis (54.20%)
- Internal medicine (44.69%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (44.69%)
- Immunology (72.57%)
- Autoimmunity (32.30%)
In recent papers he was focusing on the following fields of study:
Carlo Selmi mainly focuses on Internal medicine, Immunology, Autoimmunity, Autoantibody and Rheumatoid arthritis.
His Internal medicine study often links to related topics such as Gastroenterology.
Many of his studies on Immunology apply to Myositis as well.
His Autoimmunity study is concerned with the field of Disease as a whole.
His biological study spans a wide range of topics, including Differential diagnosis, Cancer and Arthritis.
His research investigates the connection between Cohort and topics such as Retrospective cohort study that intersect with problems in Odds ratio.
Between 2015 and 2021, his most popular works were:
- Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex. (84 citations)
- Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study (74 citations)
- The microbiome and autoimmunity: a paradigm from the gut–liver axis (67 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
His primary areas of study are Immunology, Internal medicine, Autoimmunity, Autoantibody and Immune system.
His Immunology research includes themes of Disease and Inflammatory bowel disease.
His Internal medicine research incorporates themes from Gastroenterology and Surgery.
The concepts of his Autoimmunity study are interwoven with issues in Genetic predisposition, Primary biliary cirrhosis, Antiphospholipid syndrome, Epstein–Barr virus and Lupus erythematosus.
Carlo Selmi combines subjects such as Myositis and Arthritis with his study of Autoantibody.
Carlo Selmi interconnects Systemic lupus erythematosus, Drug, Dysbiosis and Rituximab in the investigation of issues within Immune system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
